RK

Raj Kishor Bajpai

Active Director Director DIN 08470673
DIN 08470673 First appointment Jun 2019
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Raj Kishor Bajpai

Data last updated:

Raj Kishor Bajpai is a Director at Anikedix Pharma Private Limited (since 2019). Anikedix Pharma Private Limited reported revenue of ₹10.4 Lakh (FY 2024).

DIN 08470673
Primary Designation Director
First Appointment 03 Jun 2019
Oldest Company Age 7 yrs
Largest company Anikedix Pharma Private Limited · ₹10.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anikedix Pharma Private Limited U47720UP2019PTC117606
Director03 Jun 20192019₹10.4 Lakh (FY 2024)Active

Board colleagues of Raj Kishor Bajpai

NameDINCompanyDesignation
Govind Bajpai08470612Anikedix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Anikedix Pharma Private Limited
Premium access

Shareholding and investment profile for Raj Kishor Bajpai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raj Kishor Bajpai

Raj Kishor Bajpai currently holds 1 directorship: Anikedix Pharma Private Limited (Director, since 03 Jun 2019, revenue ₹10.4 Lakh (FY 2024)).

Raj Kishor Bajpai was first appointed on 03 Jun 2019 as Director at Anikedix Pharma Private Limited.

The current boards of Raj Kishor Bajpai's companies include Govind Bajpai (Anikedix Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available